Raleigh Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18K Sell
196
-18
-8% -$1.57K 0.01% 353
2026
Q1
$18.3K Buy
214
+11
+5% +$980 0.01% 356
2025
Q4
$16.1K Buy
203
+75
+59% +$5.88K 0.01% 361
2025
Q3
$10.3K Buy
128
+1
+0.8% +$85 ﹤0.01% 365
2025
Q2
$11.6K Sell
127
-5
-4% -$456 ﹤0.01% 364
2025
Q1
$12.3K Sell
132
-520
-80% -$46.6K 0.01% 350
2024
Q4
$59.3K Sell
652
-204
-24% -$19.5K 0.02% 298
2024
Q3
$88.9K Buy
856
+293
+52% +$29.9K 0.03% 263
2024
Q2
$54.6K Buy
563
+27
+5% +$2.49K 0.02% 294
2024
Q1
$48.3K Buy
536
+215
+67% +$18.2K 0.02% 300
2023
Q4
$25.6K Buy
321
+75
+30% +$5.64K 0.01% 394
2023
Q3
$17.5K Buy
+246
New +$18.4K 0.01% 418
2023
Q1
Sell
-76
Closed -$6.01K 850
2022
Q4
$6.01K Buy
76
+13
+21% +$975 ﹤0.01% 520
2022
Q3
$4K Sell
63
-3
-5% -$235 ﹤0.01% 520
2022
Q2
$5K Hold
66
﹤0.01% 437
2022
Q1
$5K Buy
+66
New +$5.23K ﹤0.01% 447

Other funds holding CL

Raleigh Capital Management's CL Position: Q2 2026 in Review

Raleigh Capital Management reduced its Colgate-Palmolive (CL) stake by 8.4% in Q2 2026, selling an estimated $1.57K and leaving 196 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #353.

Raleigh Capital Management first reported a position in CL in Q1 2022 and has held it in 16 quarters since. The position peaked at $88.9K in Q3 2024. 432 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Raleigh Capital Management held 196 shares of Colgate-Palmolive worth $18K as of Q2 2026.
  • Raleigh Capital Management sold 18 Colgate-Palmolive shares in Q2 2026, an estimated $1.57K.
  • Colgate-Palmolive made up 0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #353 holding.
  • Raleigh Capital Management first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 16 quarters since.
  • Raleigh Capital Management's Colgate-Palmolive position peaked at $88.9K in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.